Unknown

Dataset Information

Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials.


ABSTRACT:

Objectives

To assess the efficacy and safety of omalizumab for chronic rhinosinusitis with nasal polyps (CRSwNP) and to identify evidence gaps that will guide future research on omalizumab for CRSwNP.

Design

Systematic review and meta-analysis.

Data sources

A comprehensive search was performed in PubMed, Embase, Web of Science and the Cochrane Library on 13 October 2020.

Eligibility criteria

Randomised controlled trials (RCTs) comparing omalizumab with placebo, given for at least 16 weeks in adult patients with CRSwNP.

Data extraction and synthesis

Two independent authors screened search results, extracted data and assessed studies using the Cochrane risk of bias tool. Data were pooled using the inverse-variance method and expressed as mean differences (

SUBMITTER: Wu Q 

PROVIDER: S-EPMC8420736 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature